Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 09, 2024 at 02:17 am EST
Share
Caplin Point Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 4,355 million compared to INR 3,720.7 million a year ago. Revenue was INR 4,526.8 million compared to INR 3,862.2 million a year ago. Net income was INR 1,172 million compared to INR 974.8 million a year ago. Basic earnings per share from continuing operations was INR 15.44 compared to INR 12.86 a year ago. Diluted earnings per share from continuing operations was INR 15.39 compared to INR 12.75 a year ago.
For the nine months, sales was INR 12,408.8 million compared to INR 10,774.5 million a year ago. Revenue was INR 12,905.3 million compared to INR 11,220.3 million a year ago. Net income was INR 3,355 million compared to INR 2,741.5 million a year ago. Basic earnings per share from continuing operations was INR 44.19 compared to INR 36.17 a year ago. Diluted earnings per share from continuing operations was INR 44 compared to INR 35.85 a year ago.
Caplin Point Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing, and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals and sachets (liquids and powders). It also manufactures a range of ointments, creams, gels and lotions. Its principal research and development facilities are in Tamil Nadu, India. Its principal manufacturing facility is in Puducherry, India. It has presence in Latin America (LATAM), Southern Africa and Francophone Africa along with a presence in United States of America and European region. The Companyâs subsidiaries include Caplin Point Far East Limited and Caplin Steriles Limited.
CAPLIN POINT LABORATORIES LIMITED 
